We use cookies to display personalized content, analyze site traffic, provide recommendations, and ensure you have a great browsing experience. By continuing to use our site, you consent to our use of cookies. Privacy Policy.
When an ingredient cannot qualify as GRAS or requires a binding federal authorization, a Food Additive Petition (FAP) is the formal route to legal market access in the U.S. QSS works with your team to assess whether a petition is the right pathway and prepares a dossier built to meet FDA CVM's requirements.
Under the FD&C Act, any animal food substance not Generally Recognized as Safe (GRAS) is a food additive requiring premarket approval. A successful petition results in a regulation under 21 CFR Part 573, setting binding conditions of use, including species, use levels, and labelling.
FDA's Center for Veterinary Medicine oversees this under 21 CFR Part 571. Your petition must prove target animal safety and, for food-producing animals, that tissue residues are safe for human consumption, plus an environmental assessment. Review is iterative and often takes years.
A petition fits when your safety data is proprietary, your ingredient is too novel for general recognition, or a binding regulation offers more certainty than GRAS. QSS assesses your ingredient and advises on the right pathway.
Not every ingredient that cannot qualify for GRAS requires a petition, and not every petition is the right move for your business timeline. QSS evaluates your ingredient, safety data, and commercial objectives to confirm whether a food additive petition is the appropriate pathway and what it will realistically require.
CVM offers a pre-petition consultation process using Investigational Food Additive (IFA) files under GFI #262. QSS prepares your IFA file and supports your engagement with CVM before formal submission, incorporating CVM’s feedback into your petition strategy to improve dossier quality and reduce the risk of iterative delays.
QSS prepares your complete petition under 21 CFR Part 571, covering all required technical sections: ingredient identity and composition, intended use and labelling, evidence of technical effect, analytical methods, target animal safety, human food safety and proposed residue tolerances where applicable, environmental safety documentation, stability data, and the proposed regulation.
For ingredients used in food-producing animals, your petition must establish that residues in edible tissues are safe for human consumption and propose tolerances under 21 CFR Part 556. QSS develops the residue assessment and coordinates the data needed to support it.
A petition must include either an Environmental Assessment or a claim of categorical exclusion under 21 CFR Part 25. QSS prepares the appropriate documentation based on your ingredient’s profile and intended use.
The petition process involves ongoing exchange between CVM and the petitioner. QSS manages that communication, tracks the status of your petition, and prepares responses to CVM information requests throughout the review cycle.
Explore articles, blogs, and videos on animal food additive petitions, FDA CVM requirements, and ingredient approval pathways.
A food additive petition is the appropriate route when your ingredient’s safety data is primarily proprietary and cannot be made publicly available, when the ingredient is novel enough that general recognition among qualified scientific experts is difficult to establish, or when the complexity of the safety profile warrants a binding federal regulation rather than a GRAS determination. QSS assesses your ingredient and advises on the right pathway before you invest in a dossier.
A successful petition results in a regulation published in 21 CFR Part 573, which establishes the legally binding conditions of safe use for your ingredient in animal food. That regulation specifies the permitted animal species, use levels, labelling requirements, and any other conditions that apply. Unlike a GRAS “no questions” letter, a 21 CFR Part 573 regulation is a formal federal approval.
Under 21 CFR Part 571, a petition must address: the ingredient’s identity, composition, and method of manufacture; its intended use, use level, and labelling; evidence of its technical effect in animal food; validated analytical methods for detection; target animal safety data; human food safety and proposed tolerances for food-producing animal species; environmental safety documentation; stability data; and the proposed regulation text. QSS prepares all sections and ensures they meet CVM’s current data quality expectations.
The FD&C Act sets a statutory timeline of 90 days from filing, extendable to 180 days. In practice, these deadlines are rarely met. The review is iterative, with CVM requesting additional information as needed and the clock pausing during each exchange. Real-world timelines commonly run multiple years for complex ingredients. A well-prepared petition that anticipates CVM’s data requirements reduces the number of review cycles and the overall timeline.
An Investigational Food Additive (IFA) file is a pre-petition consultation mechanism under GFI #262 that allows your company to engage with CVM before formal submission. CVM reviews the IFA file and provides feedback on the adequacy of your data and the direction of your petition. Incorporating that feedback before submitting the formal petition significantly improves dossier quality and reduces the risk of extended iterative review.
For ingredients used in cattle, poultry, swine, fish, or other food-producing species, your petition must establish that residues in edible tissues are safe for human consumption. This requires residue depletion studies and the proposal of tolerance levels under 21 CFR Part 556. QSS develops the residue assessment and works with your team to identify the studies needed to support it.
Yes. AFIC and a food additive petition are not mutually exclusive. Some companies pursue AFIC to obtain near-term enforcement discretion while a formal petition proceeds through CVM review. QSS coordinates both filings to ensure consistency and avoid duplication across submissions.